Skip to main content
OpenTrials

Clinical trial condition

Treated by 177Lutetium-PSMA-617 (Lu-PSMA)

Explore clinical trials studying Treated by 177Lutetium-PSMA-617 (Lu-PSMA). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Treated by 177Lutetium-PSMA-617 (Lu-PSMA) trial results

Recruiting

Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

NCT06600802

Conditions
Castration-resistant Metastatic Prostate Cancer, Treated by 177Lutetium-PSMA-617 (Lu-PSMA)
Locations
  • Centre Jean PERRIN Clermont-Ferrand, France
  • CHU de Grenoble La Tronche, France
  • Hospices Civiles de Lyon Pierre-Bénite, France
  • Hôpital privé de la Loire Saint-Etienne, France
View Trial Details

Related conditions